Share/Refer CSATC

Doctor Administers medical Marijuana

Keeping You Informed

CSATC - New Jersey Medical Marijuana Dispensary

News

Scientific Focus: The Endocannabinoid System

Did you know that you have an endocannabinoid system?


The endocannabinoid system was initially discovered in the late 1980s when scientist studied how THC and other cannabinoids interact. Cannabis can function efficiently in mammal’s due to a series of receptors in the pathways of the brain called the endocannabinoid system (ECS).

 

Cannabinoids bind with the endocannabinoid
receptors, creating medical effects
by suppressing signals
such as pain, nausea and depression
while boosting appetite and euphoria.

 

It was discovered that humans are designed to interact with cannabinoids through the ECS which consist of CB1 and CB2 receptors. Cannabinoids and terpenes are delivered to the bloodstream either through the lungs (when inhaled), the digestive system (when consumed) or the skin (when applied topically). From the blood stream, cannabinoids become available to the central nervous system through the CB1 receptors and the immune system through CB2 receptors.

These receptors influence the flow of chemical signals to the brain and digestive system. Cannabinoids bind with the endocannabinoid receptors, creating medical effects by suppressing signals such as pain, nausea and depression while boosting appetite and euphoria. Cannabis use effects the neurotransmitter GABA by blocking it. The result is increasing dopamine levels which GABA normally inhibits or regulates. Dopamine offers a mood shift of reward for the brain that is released with sex, exercise, appetite, learning, sleep, movement and mood.

 
Cannabis effects the cannabinoid receptors, namely CB1 and CB2 that mimic a naturally created endogenous molecule, anandamide. Anandamide is an Omega 6 fatty acid that regulates appetite, cognition, emotion, memory, mood and pain. Delta-9-tetrahydrocannabinol (THC) and other cannabinoids found in cannabis can affect anandamide and therefore effect the endocannabinoid central nervous system.

 
The most exciting and promising lines of research into the role of the endocannabinoid system is in the regulation of inflammation and the immune system. Clinical evidence has shown the effectiveness of endocannabinoids on treating epilepsy, multiple sclerosis, muscle spasms and other neuromuscular system disorders.

Posted on in category: Science, Qualifying Conditions, Research | Tagged , , , | Leave a comment

Six New Strains Coming Soon

CSATC is growing six new strains that should be released by the end of the 2017. Patients find our assortment of “blue” strains to be useful in combatting many symptoms they experience. Blue Dream, Blueberry Silvertip, Blue Tahoe and Blue Widow 1 are all hybrids of the High Times’ Cannabis Cup 2000 Best Indica strain, Blueberry, which is one of the six new strains that CSATC is cultivating. Blueberry’s lineage is most often traced to the American breeder DJ Short, who created the strain when working with a variety of exotic landrace strains. According to Leafly, Blueberry is helpful for stress, pain, depression, insomnia and headaches. We expect Blueberry to be available for purchase this fall.
 

Patients find our assortment of “blue” strains
to be useful in combatting many symptoms they experience….

 
Stay tuned for future announcements about our other five strains!

Posted on in category: Dispensary News, Products, Strain Highlight | Leave a comment

More Products & Advanced Formulation Brings New Potency to CSATC’s Extractions

New Extract Products To Come
CSATC is involved in constant research and development and recently we have made headway in improving our extracted product selection. CSATC, the only alternative treatment center in the state that offers non-smoking forms of cannabis, currently produces extracted products in the form of Cocoa Butter Lotion, Lozenges and Topical Oil. We will continue to produce the current formulation for our products that consists of a 10:1 THC to CBD ratio, but we are working on an advanced formulation that will have a 1:1 THC to CBD ratio. In addition to our new formulation, we developed three new extract products that will be sent to the state shortly for approval. You can expect announcements about the products once they are approved.

…We are working on a formulation
that will have a 1:1 THC to CBD ratio….

 

 

Posted on in category: Research, Dispensary News, Products | Tagged | Leave a comment

Strain Highlight: Agent Orange & Wappa

At Compassionate Sciences™, we provide a (50×50) hybrid Agent Orange strain, which produces happy, energetic and euphoric effects that patients say works best for stress, depression, chronic pain, fatigue, nausea, anxiety, arthritis, cancer, migraines, PMS and PTSD.
 
This dynamic cannabis strain is a result of crossing Jack the Ripper and Orange Velvet. Many patients find this strain to be more uplifting than sedative. With its refreshing aroma of sweetness, citrus and oranges, patients find Agent Orange to be a great mood enhancer for use throughout their day.

Terpenes – Limonene, Myrcene
Scents – Citrus, Orange, Sweet
Effects – Happy, Energetic, Euphoric, Relaxed, Uplifted, Focused

 
 

CSATC also provides an indica dominant Wappa strain that exhibits relaxed, happy and uplifted effects that patients say works great for chronic pain, insomnia, anxiety, stress, depression and headaches.
 
This potent indica-dominant hybrid has lineage from the Skunk strain, and was bred through selecting the “juiciest” plants of each generation to build the distinct Wappa profile. Despite its indica dominance, patients find this strain helpful for both daytime and nighttime use with minimal “couch lock” effects. Patients report uplifting effects as well as a body buzz that reflects its indica dominance.

Terpenes – Myrcene, Caryophyllene
Scents – Sweet, Earthy, Pungent

Effects
– Relaxed, Happy, Uplifted, Focused
 

Posted on in category: Strain Highlight | Leave a comment

Gorilla Glue Garlic Herbed Gravy

Gorilla Glue is a great strain for conditions including Lyme disease, chronic pain, glaucoma and can help stimulate one’s appetite. The earthy flavor pairs well with the garlic/basil/parsley flavors.

 

Ingredients:
½ Cup Gorilla Glue Garlic Herbed Butter
½ Cup Flour
4 Cups Chicken Stock
1/3 Cup Heavy Cream
 
Directions:
Cut Garlic Butter into chunks and melt on stove.
Add ½ cup flour and whisk until blended.
Continue whisking until it smells like a pie is cooking!
This may take 6-12 minutes.
Add chicken stock, one cup at a time until fully blended.
Then add the heavy cream, whisking until it coats the back of a spoon.

Posted on in category: Patient Recipes | Comments Off on Gorilla Glue Garlic Herbed Gravy

Gorilla Glue Garlic Herbed Butter

Gorilla Glue is a great strain for conditions including Lyme disease, chronic pain, glaucoma and can help stimulate one’s appetite. The earthy flavor pairs well with the garlic/basil/parsley flavors.
Ingredients:
1/8 oz. Gorilla Glue
1 Cup Butter, Softened
1 Clove Garlic, pressed
2/3 Cup Chopped Basil
¼ Cup Fresh Parsley
2/4 teaspoon of salt

 

Directions:
Decarboxylate cannabis in covered, oven safe dish at 240 degrees for 45 minutes.

Place in crockpot with ½ cup of butter on low for 2 hours.
Do not strain.
Put in refrigerator until more solidified, but not completely hardened.
Stir in garlic, basil, parsley and salt until well blended.

Posted on in category: Patient Recipes | Comments Off on Gorilla Glue Garlic Herbed Butter

Strain Focus: AC/DC

At Compassionate Sciences, we provide a sativa dominant AC/DC strain, to be available by June 22, which exhibits relaxed and uplifted effects that patients say works great for seizure disorders, Multiple Sclerosis, spasms, gastrointestinal distress, anxiety, chronic pain, stress inflammation and depression.

This high CBD strain has countless sought after medicinal benefits, and does not produce psychotropic effects. When mixed with high THC strains it can take away the psychotropic effects of THC, while still allowing patients to receive the medicinal benefits of both strains.

AC/DC is a hybrid cross of MK ultra and G13 Haze. MK Ultra is named after a CIA Project that implemented mental manipulation methods, and is known for its strong and fast acting “hypnotic” effects. G13 Haze is a hybrid producing uplifting sensations while retaining a heavy indica undertone. Renowned for its medical use, G13 Haze was bred for potency. The cross of MK Ultra and G13 Haze resulted in AC/DC, a phenotype of the cannabis strain Cannatonic.

With its distinct lineage and wide range of medicinal benefits, AC/DC is a patient favorite.

 

Click to read more about strains at CSATC.

Posted on in category: Strain Highlight | Comments Off on Strain Focus: AC/DC

Patients Not Allowed to Smoke in Seaside Boardwalk’s Smoking Section

Patients were told that smoking medical cannabis on the Seaside Boardwalk, even if it is in the designated smoking section, is not allowed. Although patients have the right to smoke where the law allows them, there are restrictions that limit medicating in certain public places.

Michelle Burns, who suffers from multiple sclerosis, was quickly interrupted while trying to medicate in the designated smoking section on the boardwalk.

As shown in this video, she was confronted by a group of officers, one of the officers stated that no one has ever even explained the “medical marijuana” laws to them. Even though it is argued in the video that CUMMA allows medical marijuana patients to smoke where the Clean Air Act permits them, there are exceptions to the overarching rule. CSATC encourages all patients to review CUMMA and to respect the guidelines provided by the Department of Health stated below.

The Department of Health provides guidelines for patients which say:

“Patients are encouraged to use medicinal marijuana only in their residence. Patients may not smoke medicinal marijuana in a school bus, on public transportation, or in a private vehicle while in motion. Additionally, patients may not smoke medicinal marijuana on any school grounds or at any correctional facility, public park, beach, recreation center or other places where smoking is prohibited.”

The officers clarified that the boardwalk is considered a recreation area, and this understanding was reinforced at a subsequent council meeting. The borough attorney said that they may consider altering this rule. Overall, it did not seem to be a hostile encounter with the police officers. The patients in the video were cooperative and understanding, and the officers gave suggestions on where they could medicate without being bothered by law enforcement.

Posted on in category: New Jersey News | Tagged , , | Comments Off on Patients Not Allowed to Smoke in Seaside Boardwalk’s Smoking Section

CSATC’s Improvements, New Strains and More

Since CSATC entered the cannabis industry in New Jersey, our goal has always been to continue to improve the Medical Marijuana Program. We recognize the realities of being a patient in New Jersey; a program structure that is expensive and one that limits patients’ access to high grade medical cannabis. Considering that there are only five alternative treatment centers in New Jersey, from the onset, CSATC has made constant efforts to provide patients with greater accessibility to the most affordable and the highest quality medicine.

CSATC is involved in constant research and development. We recently purchased new extraction instrumentation to improve the quality of our extract products. The new upgrade enhances our extracting ability by eliminating the post decarboxylation process. Eliminating this process minimizes the degradation of concentrate, which results in an increased clarity in our oil. In addition, our extract process has recently been enhanced, and utilizes a two stage distillation process to fully remove waxes allowing for higher concentration recovery and less non-targeted compounds. These recent improvements in our extracting abilities are noticeable in the physical clarity of our topical oil as well as improved taste, smell and provide an increase in the clarity of effects among our extract products.

Largest and most consistent variety of medical cannabis strains. Our growers are constantly working to improve strains by methodically adjusting grow conditions to maximize the medicinal components for patients. We are currently growing six new strains that will be announced before the end of the year. CSATC’s patient base is constantly growing, and to match the demand, our facility has been approved to expand an additional 23,000 square feet giving room for an additional 500 lights. In the short term, this will allow CSATC to grow enough medicine to supply our growing patient base. Our long term plan is to turn our existing building into our cultivation and processing location, and open a larger, better suited CSATC dispensary across the street from our existing location.

These efforts will enhance CSATC’s ability to provide the highest quality medical cannabis strains and products at even more affordable prices. Our mission is to help relieve the pain and suffering of patients with serious diseases, and in order to accomplish this goal, CSATC has implemented different initiatives to make our medical cannabis more accessible and affordable for patients in the New Jersey Medical Marijuana Program.

Pricing
When CSATC opened, our prices were set below market value, but we knew that this wouldn’t be the end of our effort to improve patients’ access to medicine. Since then, we have expanded our hours of operation instituting the largest range of hours in the state for patients to purchase medicinal cannabis.

CSATC is unique in that our prices can be taken at face value. The prices patients see already includes the 6.875 percent state sales tax. CSATC is currently lobbying for the removal of the medical cannabis state sales tax, which would further reduce prices for patients. Over the past three months CSATC has reduced flower prices by more than 20 percent on over 12 top strains, and has increased the variety of featured strains in hopes that more patients will find the right strains for their debilitating medical condition. We also offer additional discounts including the Veteran’s Discount of 20%, the Compassionate Discount of 20% for those on government assistance and a Minor’s Discount of 40%.

As part of our hands-on approach to improve the New Jersey cannabis industry for patients, Executive Director George Schidlovsky has positioned himself on the board of directors for the New Jersey CannaBusiness Association, a powerful and active association whose mission is to guide the decision makers and regulators in the budding cannabis industry to understand and respect the needs of the CannaBusiness community.

 

Posted on in category: Cannabis News, New Jersey News, Dispensary News | Comments Off on CSATC’s Improvements, New Strains and More

Concerns Regarding The Supply of Hemp Based CBD from Sources Outside of The New Jersey Medical Marijuana Program

Recently, some of our patients have been exploring other sources of CBD and trying new Hemp-based products. It’s important to be aware that Hemp-based CBD is not always what it claims to be. Our major concern with the supply of Hemp based CBD from sources outside of the New Jersey Medical Marijuana Program (MMP) is that these sources do not adhere to the same rigorous growing and testing criteria of the New Jersey MMP, and may be exposing already suffering patients to harmful chemicals or pesticides.

Sources of CBD from industrial hemp raises multiple concerns. Industrial hemp is not restricted in the use of pesticides and fertilizers as New Jersey medical cannabis is. Hemp, a known bioaccumulator, will absorb and collect these contaminants that can cause serious health problems if ingested. Also, companies producing these CBD products may purchase hemp from sources outside the U.S. further raising health concerns if these products are safe for patients to consume. The state of New Jersey tests all of the medical marijuana products produced in the state for consumption, and these outsourced CBD products are not tested within the state criteria.

 

Posted on in category: Cannabis News | Tagged , , , | Comments Off on Concerns Regarding The Supply of Hemp Based CBD from Sources Outside of The New Jersey Medical Marijuana Program
Top